Cognitive effects of repetitive transcranial magnetic stimulation in patients with neurodegenerative diseases - clinician's perspective

J Neurol Sci. 2014 Apr 15;339(1-2):15-25. doi: 10.1016/j.jns.2014.01.037. Epub 2014 Feb 4.

Abstract

Repetitive transcranial magnetic stimulation (rTMS) represents a promising tool for studying and influencing cognition in people with neurodegenerative diseases. This procedure is noninvasive and painless, and it does not require the use of anesthesia or pharmacological substances. In this systematic critical review we report outcomes from research focused on behavioral cognitive effects induced by rTMS in patients with Alzheimer's disease (AD), Parkinson's disease (PD), and mild cognitive impairment (MCI) preceding AD. There are still major limitations to rTMS use, such as a poor understanding of its after-effects and inter-individual variability in their magnitude, discrepancies in stimulation protocols and study designs, varied selection of the specific stimulated areas and control procedures, and neuropsychological methods for assessment of after-effects; hence, the results of the present research can only be considered preliminary. The future directions are discussed.

Keywords: Alzheimer's disease; Cognition; MCI; Neurodegenerative; Parkinson's disease; Systematic review; rTMS.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review
  • Systematic Review

MeSH terms

  • Alzheimer Disease / diagnosis
  • Alzheimer Disease / psychology
  • Alzheimer Disease / therapy
  • Animals
  • Cognition* / physiology
  • Cognitive Dysfunction / diagnosis
  • Cognitive Dysfunction / psychology
  • Cognitive Dysfunction / therapy
  • Humans
  • Neurodegenerative Diseases / diagnosis
  • Neurodegenerative Diseases / psychology*
  • Neurodegenerative Diseases / therapy*
  • Parkinson Disease / diagnosis
  • Parkinson Disease / psychology
  • Parkinson Disease / therapy
  • Physician's Role*
  • Transcranial Magnetic Stimulation / methods*